Pacific Biosciences Of California Price to Book Ratio 2010-2025 | PACB
Historical price to book ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The current price to book ratio for Pacific Biosciences Of California as of May 22, 2025 is 3.08.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pacific Biosciences Of California Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-23 | 0.92 | 3.02 | |
| 2025-03-31 | 1.18 | $0.31 | 3.86 |
| 2024-12-31 | 1.83 | $1.72 | 1.06 |
| 2024-09-30 | 1.70 | $1.65 | 1.03 |
| 2024-06-30 | 1.37 | $1.81 | 0.76 |
| 2024-03-31 | 3.75 | $2.38 | 1.57 |
| 2023-12-31 | 9.81 | $2.62 | 3.75 |
| 2023-09-30 | 8.35 | $2.96 | 2.82 |
| 2023-06-30 | 13.30 | $2.56 | 5.19 |
| 2023-03-31 | 11.58 | $2.77 | 4.18 |
| 2022-12-31 | 8.18 | $2.49 | 3.29 |
| 2022-09-30 | 5.81 | $2.77 | 2.09 |
| 2022-06-30 | 4.42 | $3.03 | 1.46 |
| 2022-03-31 | 9.10 | $3.27 | 2.78 |
| 2021-12-31 | 20.46 | $3.58 | 5.72 |
| 2021-09-30 | 25.55 | $3.81 | 6.70 |
| 2021-06-30 | 34.97 | $1.30 | 26.94 |
| 2021-03-31 | 33.31 | $1.41 | 23.55 |
| 2020-12-31 | 25.94 | $1.74 | 14.87 |
| 2020-09-30 | 9.87 | $0.72 | 13.71 |
| 2020-06-30 | 3.45 | $0.27 | 12.86 |
| 2020-03-31 | 3.06 | $0.39 | 7.80 |
| 2019-12-31 | 5.14 | $0.36 | 14.33 |
| 2019-09-30 | 5.16 | $0.33 | 15.48 |
| 2019-06-30 | 6.05 | $0.50 | 12.21 |
| 2019-03-31 | 7.23 | $0.62 | 11.64 |
| 2018-12-31 | 7.40 | $0.76 | 9.75 |
| 2018-09-30 | 5.41 | $0.89 | 6.11 |
| 2018-06-30 | 3.55 | $0.65 | 5.48 |
| 2018-03-31 | 2.05 | $0.78 | 2.63 |
| 2017-12-31 | 2.64 | $0.74 | 3.57 |
| 2017-09-30 | 5.25 | $0.87 | 6.02 |
| 2017-06-30 | 3.56 | $1.00 | 3.55 |
| 2017-03-31 | 5.17 | $0.74 | 6.99 |
| 2016-12-31 | 3.80 | $0.91 | 4.16 |
| 2016-09-30 | 8.96 | $1.07 | 8.41 |
| 2016-06-30 | 7.04 | $1.19 | 5.91 |
| 2016-03-31 | 8.50 | $1.02 | 8.33 |
| 2015-12-31 | 13.13 | $0.92 | 14.28 |
| 2015-09-30 | 3.66 | $0.55 | 6.70 |
| 2015-06-30 | 5.76 | $0.45 | 12.76 |
| 2015-03-31 | 5.84 | $0.54 | 10.76 |
| 2014-12-31 | 7.84 | $0.74 | 10.55 |
| 2014-09-30 | 4.91 | $0.75 | 6.57 |
| 2014-06-30 | 6.18 | $0.84 | 7.40 |
| 2014-03-31 | 5.35 | $1.07 | 4.99 |
| 2013-12-31 | 5.23 | $1.04 | 5.01 |
| 2013-09-30 | 5.52 | $1.26 | 4.37 |
| 2013-06-30 | 2.53 | $1.54 | 1.64 |
| 2013-03-31 | 2.49 | $1.76 | 1.41 |
| 2012-12-31 | 1.70 | $1.95 | 0.87 |
| 2012-09-30 | 1.83 | $2.29 | 0.80 |
| 2012-06-30 | 2.17 | $2.66 | 0.82 |
| 2012-03-31 | 3.42 | $3.02 | 1.13 |
| 2011-12-31 | 2.80 | $3.48 | 0.80 |
| 2011-09-30 | 3.21 | $3.84 | 0.83 |
| 2011-06-30 | 11.70 | $4.32 | 2.71 |
| 2011-03-31 | 14.05 | $4.70 | 2.99 |
| 2010-12-31 | 15.91 | $5.30 | 3.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.283B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.503B | 85.19 |
| Thermo Fisher Scientific (TMO) | United States | $151.179B | 18.29 |
| Edwards Lifesciences (EW) | United States | $43.872B | 28.76 |
| Alcon (ALC) | Switzerland | $42.488B | 28.71 |
| IDEXX Laboratories (IDXX) | United States | $40.599B | 46.66 |
| DexCom (DXCM) | United States | $33.262B | 51.41 |
| STERIS (STE) | Ireland | $23.954B | 26.41 |
| IQVIA Holdings (IQV) | United States | $23.881B | 13.38 |
| Mettler-Toledo (MTD) | United States | $23.609B | 28.08 |
| Waters (WAT) | United States | $20.737B | 29.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.307B | 0.00 |
| Hologic (HOLX) | United States | $12.141B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $10.330B | 81.08 |
| Masimo (MASI) | United States | $8.128B | 29.98 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.553B | 0.00 |
| Teleflex (TFX) | United States | $5.344B | 8.82 |
| TransMedics (TMDX) | United States | $4.172B | 90.69 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.354B | 14.02 |
| Veracyte (VCYT) | United States | $2.146B | 30.11 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.990B | 17.89 |
| Alphatec Holdings (ATEC) | United States | $1.824B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.375B | 0.00 |
| Artivion (AORT) | United States | $1.215B | 113.84 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.665B | 33.73 |
| RxSight (RXST) | United States | $0.646B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.603B | 13.19 |
| NeuroPace (NPCE) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.98 |
| Delcath Systems (DCTH) | United States | $0.562B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.33 |
| AxoGen (AXGN) | United States | $0.498B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| 908 Devices (MASS) | United States | $0.170B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.116B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.80 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 16.45 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Hyperfine (HYPR) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.041B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.75 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |